Alkermes’ schizophrenia drug shows lower weight gain than comparator

The company plans to file a New Drug Application next year. An analyst wrote that it’s unclear if the drug will require review by an advisory committee.

Article Source: Alkermes’ schizophrenia drug shows lower weight gain than comparator.